WT
GMAB icon

Whittier Trust’s Genmab GMAB Stock Holding History

Whittier Trust’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112 Buy
+4
New +$106 ﹤0.01% 1344
2024
Q3 		– Sell
-110
Closed -$2.76K – 1558
2024
Q2 		$2.76K Buy
+110
New +$3.12K ﹤0.01% 1405
2020
Q3 		– Sell
-34
Closed -$1K – 1451
2020
Q2 		$1K Hold
34
– – ﹤0.01% 1329
2020
Q1 		$1K Buy
+34
New +$758 ﹤0.01% 1387

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Whittier Trust's GMAB Position: Q2 2026 in Review

Whittier Trust opened a new position in Genmab (GMAB) in Q2 2026: 4 shares worth $112. The stake represents ﹤0.01% of the portfolio and ranks #1344 among its holdings. This is a return to the name: Whittier Trust previously reported a position in GMAB as recently as Q2 2024.

Whittier Trust first reported a position in GMAB in Q1 2020 and has held it in 4 quarters since. The position peaked at $2.76K in Q2 2024. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Whittier Trust held 4 shares of Genmab worth $112 as of Q2 2026.
  • Genmab was a new Whittier Trust position in Q2 2026.
  • Genmab made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #1344 holding.
  • Whittier Trust first reported a position in Genmab in Q1 2020 and has held it in 4 quarters since.
  • Whittier Trust's Genmab position peaked at $2.76K in Q2 2024.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.